Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Year range
1.
Indian J Exp Biol ; 2014 Apr; 52(4): 375-382
Article in English | IMSEAR | ID: sea-150369

ABSTRACT

The first set of competitive inhibitors of molt inhibiting hormone (MIH) has been developed using the effective approaches such as Hip-Hop, virtual screening and manual alterations. Moreover, the conserved residues at 71 and 72 positions in the molt inhibiting hormone is known to be significant for selective inhibition of ecdysteroidogenesis; thus, the information from mutation and solution structure were used to generate common pharmacophore features. The geometry of the final six-feature pharmacophore was also found to be consistent with the homology-modeled MIH structures from various other decapod crustaceans. The Hypo-1, comprising six features hypothesis was carefully selected as a best pharmacophore model for virtual screening created on the basis of rank score and cluster processes. The hypothesis was validated and the database was virtually screened using this 3D query and the compounds were then manually altered to enhance the fit value. The hits obtained were further filtered for drug-likeness, which is expressed as physicochemical properties that contribute to favorable ADME/Tox profiles to eliminate the molecules exhibit toxicity and poor pharmacokinetics. In conclusion, the higher fit values of CI-1 (4.6), CI-4 (4.9) and CI-7 (4.2) in conjunction with better pharmacokinetic profile made these molecules practically helpful tool to increase production by accelerating molt in crustaceans. The use of feeding sub-therapeutic dosages of these growth enhancers can be very effectively implemented and certainly turn out to be a vital part of emerging nutritional strategies for economically important crustacean livestock.


Subject(s)
Amino Acid Sequence , Animals , Arthropod Proteins/antagonists & inhibitors , Arthropod Proteins/chemistry , Arthropod Proteins/metabolism , Binding, Competitive , Crustacea/metabolism , Drug Design , Guanylate Cyclase/antagonists & inhibitors , Guanylate Cyclase/chemistry , Guanylate Cyclase/metabolism , Invertebrate Hormones/antagonists & inhibitors , Invertebrate Hormones/chemistry , Invertebrate Hormones/metabolism , Models, Molecular , Molecular Sequence Data , Sequence Homology, Amino Acid
2.
Braz. j. med. biol. res ; 34(1): 75-80, Jan. 2001. tab
Article in English | LILACS | ID: lil-277059

ABSTRACT

One of the best known crustacean hormones is the crustacean hyperglycemic hormone (CHH). However, the mechanisms involved in hormone release in these animals are poorly understood, and thus constitute the central objective of the present study. Different groups of crustaceans belonging to diverse taxa (Chasmagnathus granulata, a grapsid crab and Orconectes limosus, an astacid) were injected with serotonin, fluoxetine, or a mixture of both, and glycemic values (C. granulata and O. limosus) and CHH levels (O. limosus) were determined after 2 h in either submerged animals or animals exposed to atmospheric air. Both serotonin and fluoxetine caused significant hyperglycemia (P<0.05) after injection into the blood sinus of the two species, an effect enhanced after exposure to atmospheric air. In C. granulata blood glucose increased from 6.1 to 43.3 and 11.4 mg/100 ml in submerged animals and from 5.7 to 55.2 and 22.5 mg/100 ml in air-exposed animals after treatment with serotonin and fluoxetine, respectively. In O. limosus the increases were from 1.2 to 59.7 and 135.2 mg/100 ml in submerged animals and from 2.5 to 200.3 and 193.6 mg/100 ml in air-exposed animals after treatment with serotonin and fluoxetine, respectively. Serotonin and fluoxetine also caused a significant increase in the circulating levels of CHH in O. limosus, from 11.9 to 43 and 45.7 fmol/ml in submerged animals and from 13.2 to 32.6 and 45.7 fmol/ml in air-exposed animals, respectively, thus confirming their action as neuroregulators in these invertebrates


Subject(s)
Animals , Male , Blood Glucose/drug effects , Crustacea/metabolism , Fluoxetine/pharmacology , Free Radical Scavengers/pharmacology , Serotonin Uptake Inhibitors/pharmacology , Serotonin/pharmacology , Astacoidea/metabolism , Blood Glucose/physiology , Brachyura/metabolism , Hemolymph/chemistry , Hyperglycemia/chemically induced , Ovary/metabolism
4.
Braz. j. med. biol. res ; 24(3): 267-70, mar. 1991.
Article in English | LILACS | ID: lil-99562

ABSTRACT

The effect of crustacean hyperglycemic hormone (CHH) was investigated on the hemolymph of Chasmagnathus granulata, a meso-supralitoral crab from southern Brazil. Serum glucose increased significantly (P®0.05) after incubation of total hemolymph in the presence of the eyestalk extract of a member of the same species. Also glucose uptake from blood serum, not affected by eyestalk extract (P¼0.05) was observed after incubation of total hemolymph in the presence of glucose.The results that the hemolymph may be a target tissue of CHH and that this hormone may act by mobilizing carbohydrate reserves possibly from hematocytes.


Subject(s)
Animals , Brachyura/metabolism , Crustacea/metabolism , Hemolymph/metabolism , Invertebrate Hormones/metabolism , Blood Glucose/metabolism , Carbohydrates/metabolism , Glucose/metabolism , Glycogen/metabolism
7.
Indian J Exp Biol ; 1966 Jan; 4(1): 34-6
Article in English | IMSEAR | ID: sea-56675
SELECTION OF CITATIONS
SEARCH DETAIL